Open Accessibility Menu

Transcatheter Aortic Valve Replacement (TAVR)

TAVR is the name for a new procedure in cardiology and cardiac surgery that enables patients with a condition called severe aortic stenosis (narrowing of the aortic heart valve opening) to receive a new heart valve without undergoing open-heart surgery. Traditionally, the primary treatment for aortic stenosis has been surgery. However, certain patients with severe stenosis were considered too sick for surgery.

As a result of a pivotal new Partner Trial, the FDA has approved the use of the Edwards' Transcatheter Heart Valve, which utilizes a minimally invasive procedure to implant a new valve using a method very similar to the implantation of a stent. Therefore, these patients can now receive a new valve without surgery and there is now hope for those whose conditions were previously thought to be untreatable.